Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Terevalefim (ANG-3777) is an hepatocyte growth factor (HGF) mimetic. Terevalefim selectively activates the c-Met receptor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 97.00 | |
5 mg | In stock | $ 137.00 | |
10 mg | In stock | $ 248.00 | |
25 mg | In stock | $ 491.00 | |
50 mg | In stock | $ 815.00 | |
100 mg | In stock | $ 1,487.00 | |
200 mg | In stock | $ 2,227.00 | |
500 mg | In stock | $ 3,347.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 163.00 |
Description | Terevalefim (ANG-3777) is an hepatocyte growth factor (HGF) mimetic. Terevalefim selectively activates the c-Met receptor. |
In vitro | Terevalefim (ANG-3777) (0-10 μM) significantly inhibited cancer cells proliferation in HUVECs[2]. |
In vivo | Terevalefim (ANG-3777) decreases apoptosis, increases proliferation, and promotes organ repair and function in animal models[1].Terevalefim (ANG-3777, 40 mg/kg, IP) phosphorylates the c-Met receptor in rats[2]. |
Molecular Weight | 176.24 |
Formula | C9H8N2S |
CAS No. | 1070881-42-3 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 100 mg/mL (567.41 mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Terevalefim 1070881-42-3 Tyrosine Kinase/Adaptors c-Met/HGFR ANG-3777 injury acute inhibit ANG 3777 AKI kidney ANG3777 transplantation HGF Inhibitor inhibitor